Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis

20001,243 citationsJournal Articlebronze Open Access

Authors

Daniel J. Lovell · Cincinnati Children's Hospital Medical Center

Edward H. Giannini · Cincinnati Children's Hospital Medical Center

Andreas Reiff · Children's Hospital of Los Angeles

Gail Dunkel Cawkwell

Earl D. Silverman · University College London

James J. Nocton · Medical College of Wisconsin

Leonard D. Stein · University of North Carolina at Chapel Hill

Abstract

Treatment with etanercept leads to significant improvement in patients with active polyarticular juvenile rheumatoid arthritis. Etanercept is well tolerated by pediatric patients.

Topics & Keywords

Autoimmune and Inflammatory Disorders Research Kawasaki Disease and Coronary Complications Immunodeficiency and Autoimmune Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 342, Issue 11, pp. 763-769

DOI: 10.1056/nejm200003163421103

Field-Weighted Citation Impact: 33.70